Sam Altman is reportedly telling Hollywood studios and other copyright owners that OpenAI's new Sora is going to use their work without permission.

The billionaire owner of Cost Plus Drugs is giving the Trump administration's announced website, TrumpRx.gov, a "B" for now.

Zeta, which helps marketers attract and retain customers, is doubling down on a strategy to get its clients to use more than one of its services.

Federal workers received an email Tuesday, saying that a looming government shutdown will come with furloughs.

My son and I moved from the US to Barcelona when he was 3. It took us time to find our place and I made some mistakes along the way.

Wolfspeed stock is surging after the company's emergence from bankruptcy. Retail traders online have zeroed in on the chipmaker's meme-like rally.

Donald Trump announced an agreement with Pfizer to make their drugs available to Medicaid at a lower price.

Hegseth set the direction for the Department of Defense, telling the officers present that if they don't like it, they should resign.

From nostalgic chocolate milk to adaptogen-rich shakes, here's how 14 protein drinks compare.

The modern take on Shakespeare's "The Taming of the Shrew," starring Julia Stiles and Heath Ledger, is now streaming on Netflix.

Moves in two seemingly unrelated stocks on Tuesday point to the new investing reality in 2025. Here's what's going on with CoreWeave and Pfizer.

Analysts told BI TikTok's $14 billion deal secures its US future and signals a middle ground in the fraught US-China tech rivalry.